Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
FluoroPharma Medical Inc. (FPMI) had Return on Tangible Equity of 19.60% for the most recently reported fiscal year, ending 2016-12-31.
| Income Statement Financials | |
-- |
|
$-2.57M |
|
-- |
|
-- |
|
$2.20M |
|
$-2.20M |
|
$0.15M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.20M |
|
$-1.21M |
|
33.56M |
|
33.56M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$0.05M |
|
$0.01M |
|
$0.29M |
|
$0.33M |
|
$10.51M |
|
-- |
|
-- |
|
$10.51M |
|
$-10.18M |
|
$-10.46M |
|
$-10.18M |
|
34.07M |
|
| Cash Flow Statement Financials | |
$-0.88M |
|
$-0.00M |
|
$0.62M |
|
$0.29M |
|
$0.02M |
|
$-0.27M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
20.13% |
|
|
Return on Tangible Equity |
19.60% |
-612.34% |
|
20.14% |
|
$-0.30 |
|
$-0.03 |
|
$-0.03 |
|